Our customers and partners continue to expand on an increasing body of literature, carrying out studies with the help of Invitron's diagnostic test kits.

Sample Publications

Below are sample publications of research carried out with the help of Invitron diagnostic test kits:

Insulin assays

Manley SE, Stratton IM, Clark PM, Luzio SD. Clin Chem. 2007 May;53(5):922-32.Comparison of 11 Human Insulin Assays: Implications for Clinical Investigation and Research.
> View abstract

Cozma LS, Luzio SD, Dunseath GJ, Langendorg KW, Pieber T, Owens DR.  Diabetes Care 2002; 25: 1271-1276.
Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.
> View abstract

Pfützner A, Langenfeld M, Kunt T, Löbig M, Forst T. Clin Lab. 2003;49(11-12):571-6. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
> View abstract

Peter R, Luzio SD, Dunseath G, Miles A, Hare B, Backx k, Pauvaday V, Owens DR. Effects of exercise on the absorption of insulin glargine in patients with type 1 diabetes. Diabetes Care 2005; 28: 560-565.

> View abstract

Cozma LS, Luzio SD, Dunseath GJ, Underwood PM, Owens DR. β-cell response during a test meal: a comparative study of incremental doses of repaglinide in type 2 diabetic patients. Diabetes Care 2005; 28: 1001-1007.
> View abstract

Butter NL, Hattersley AT, Clark PM.  Clin Chim Acta. 2001; 310: 141-150.
Development of a bloodspot assay for insulin.
> View abstract

Shields BM, Knight B, Shakespeare L, Babrah J, Powell RJ, Clark PM, Hattersley AT. Determinants of insulin concentrations in healthy 1-week-old babies in the community: Applications of a bloodspot assay. Early Human Development 2006; 82: 143-148.
> View abstract


Proinsulin assays

Luzio SD, Lucas I, Owens DR. Importance of validation of immunoassays for intact proinsulin. Clin Chem Lab Med. 2001; 39(7): 631-633.
> View abstract

Pfützner A, Kunt T, Langenfeld M, Löbig M, Knesovic M, Forst T. Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin. Clin Chem Lab Med. 2003;41(9):1234-8.
> View abstract

Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes. Diabetes Care. 2004;27(3):682-7.
> View abstract

Pfützner A, Kann PH, Pfützner AH, Kunt T, Larbig M, Weber MM, Forst T. Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance. Clin Lab. 2004;50(9-10):567-73.
> View abstract

Langenfeld MR, Forst T, Standl E, Strotmann H-J, Lübben G, Pahler S, Kann P, Pfützner A. IRIS II Study: Sensitivity and Specificity of Intact Proinsulin, Adiponectin, and the Proinsulin/Adiponectin Ratio as Markers for Insulin Resistance. Diabetes Technol Ther. 2004;6(6):836-43.
> View abstract

Pfützner A, Standl E, Hohberg C, Strotmann HJ, Lübben G, Langenfeld MR, Schulze J, Forst T. IRIS II Study: Intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design. Diabetes Technol Ther. 2005; 7(3): 478-486.
> View abstract


C-Peptide assays

Luzio SD, Dunseath G, Lockett A, Broke-Smith TP, New RR, Owens DR.
The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes.
> View abstract